Developer docs
API playgroundTry for free, no card

Search company profiles

Xantis Pharma

Full company profile

uuid003j3hm

Namestring
Xantis Pharma
Legal namestring
Xantis Pharma AG
Websiteurl
xantispharma.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Xantis Pharma AG is a privately held Swiss pharmaceutical company headquartered in Zug, Switzerland, founded in 2015, that manufactures and distributes generic prescription (Rx) and over-the-counter (OTC) medicines with a focus on affordability and safety. The company's core technology is generic pharmaceutical manufacturing across multiple therapeutic areas including cardiology (telmisartan, perindopril, rivaroxaban, furosemide), CNS (pregabalin, zolpidem, fingolimod), gastroenterology (itopride), men's health (tadalafil, sildenafil, silodosin, dutasteride/tamsulosin), allergy (desloratadine), and arthritis/pain management (meloxicam, paracetamol combinations, tramadol), anchored by the leading Sanorin OTC brand for cough, cold, and nasal decongestants including the Sanorin Aqua medical device line.

The company operates through wholly-owned subsidiaries in Slovakia (Xantis Pharma s.r.o.) and the Czech Republic, distributing products via a B2B sales-led model to pharmacies, doctors, and wholesalers across Russia, Ukraine, the CIS region, and Central Europe. Revenue is generated through one-time sales of pharmaceutical products with no subscription or licensing model; pricing is not publicly disclosed. The product portfolio also includes antibiotics (MEGAMOX, CIPROLON, CEFIZOX, CEDROX), antifungals (voriconazole), corticosteroids, proton pump inhibitors, and dietary supplements, with the company targeting future expansion into hospital pharmacy tender markets.

Short descriptiontext

Xantis Pharma AG is a Swiss-headquartered generic pharmaceutical manufacturer distributing affordable Rx and OTC medicines, anchored by the Sanorin brand, to pharmacies, doctors, and wholesalers across Russia, Ukraine, CIS, and Central Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersZug, Switzerland
HQ citystring
Zug
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical manufacturing, over-the-counter medications, cardiovascular drug formulations, antibiotic and antifungal products, medical device manufacturing
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Xantis Pharma generates revenue through the sale of generic prescription (Rx) and over-the-counter (OTC) pharmaceutical products to pharmacies, doctors, and wholesalers. The product portfolio includes branded generics and established OTC brands like Sanorin.

xantispharma.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Sanorin
Description

Leading brand for cough and cold and nasal decongestants. Includes Sanorin 1‰, Sanorin 0.5‰, Sanorin Emulzia, Sanorin Combi, and Sanorin Aqua line of nasal sprays.

xantispharma.com
Core offering1 text field

Xantis Pharma manufactures and distributes a broad portfolio of generic prescription pharmaceuticals, over-the-counter (OTC) medicines, medical devices, and dietary supplements. Its product range covers cardiology, central nervous system, gastroenterology, men's health, allergy, arthritis, pain management, antibiotics, antifungals, and corticosteroids, marketed across Russia, Ukraine, CIS countries, and Central Europe under brands such as Sanorin and Sanimun.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Xantis Pharma is a pharmaceutical company focused on making affordable, high-quality generic medicines accessible to those who need them. The company's product portfolio comprises a broad range of offerings organized into distinct categories: (1) The Sanorin OTC sub-brand for cough, cold, and nasal decongestants including Sanorin Aqua medical devices; (2) Prescription medications spanning cardiology (Telmisartan, Perindopril, Furosemid, Rivaroxaban), central-nervous systems (Pregabalin, Zolpidem, Fingolimod), gastroenterology (Itoprid), men's health (Tadalafil, Sildenafil, Silodosin, Dutasterid/Tamsulozin), allergy (Desloratadin), arthritis and pain management (Meloxikam, Paracetamol combinations, Tramadol); (3) Antibiotics (MEGAMOX, CIPROLON, CEDROX, CEFIZOX); (4) Antifungals (Voriconazole); (5) Corticosteroids (Metylprenizolon); and (6) Dietary supplements (Sanimun). The company supplies pharmacies, doctors, and wholesalers in Russia, Ukraine, CIS, and Central Europe, with plans to enter tender markets for hospital pharmacies.

Product and service40 records
1Sanorin OTC brand (cough, cold, nasal decongestants)
CategoryOver-the-counter respiratory medicines
Description

Over-the-counter Sanorin brand products for cough, cold, and nasal congestion relief, sold to retail pharmacies and consumers in target markets.

2Sanorin Aqua (medical device nasal sprays)
3Sanimun (dietary supplement)
4Carsaxa 100 mg
5Desloratadin Xantis
6Entecavir Xantis
7Furosemid Xantis
8Itoprid Xantis
9Perindopril Xantis
10Telmisartan Xantis (40 mg and 80 mg)
11Telmisartan/Hydrochlorotiazid Xantis
12Rivaroxaban Xantis
13Moxtenz
14Tadalafil Xantis
15Sildenafil Xantis
16Silodosin Xantis
17Dutasterid/Tamsulozin Xantis
18Pregabalin Xantis
19Zolpidem Xantis
20Fingolimod Xantis
21Sunitinib Xantis
22Solixa
23Azelsan
24Lanxib
25Modrasil
26Paracetamol Xantis
27Paracetamol/Kofein Xantis
28Meloxikam Xantis
29Tramadol/Paracetamol Xantis
30Tiaprid Xantis
31Kyselina Acetylsalicylova Xantis (acetylsalicylic acid)
32Metoprolol Xantis
33MEGAMOX (amoxicillin)
34CIPROLON 500 (ciprofloxacin)
35CEFIZOX (ceftizoxime)
36CEDROX (cefadroxil)
37Voriconazole Hikma
38Metylprenizolon Hikma (methylprednisolone)
39OPRAZOLE (omeprazole)
40TRIFED and TRIFED EXPECTORANT
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Xantis Pharma

Generic Pharmaceuticalsxantispharma.com

Xantis Pharma AG is a Swiss-headquartered generic pharmaceutical manufacturer distributing affordable Rx and OTC medicines, anchored by the Sanorin brand, to pharmacies, doctors, and wholesalers across Russia, Ukraine, CIS, and Central Europe.

What Xantis Pharma does

Xantis Pharma AG is a privately held Swiss pharmaceutical company headquartered in Zug, Switzerland, founded in 2015, that manufactures and distributes generic prescription (Rx) and over-the-counter (OTC) medicines with a focus on affordability and safety. The company's core technology is generic pharmaceutical manufacturing across multiple therapeutic areas including cardiology (telmisartan, perindopril, rivaroxaban, furosemide), CNS (pregabalin, zolpidem, fingolimod), gastroenterology (itopride), men's health (tadalafil, sildenafil, silodosin, dutasteride/tamsulosin), allergy (desloratadine), and arthritis/pain management (meloxicam, paracetamol combinations, tramadol), anchored by the leading Sanorin OTC brand for cough, cold, and nasal decongestants including the Sanorin Aqua medical device line.

The company operates through wholly-owned subsidiaries in Slovakia (Xantis Pharma s.r.o.) and the Czech Republic, distributing products via a B2B sales-led model to pharmacies, doctors, and wholesalers across Russia, Ukraine, the CIS region, and Central Europe. Revenue is generated through one-time sales of pharmaceutical products with no subscription or licensing model; pricing is not publicly disclosed. The product portfolio also includes antibiotics (MEGAMOX, CIPROLON, CEFIZOX, CEDROX), antifungals (voriconazole), corticosteroids, proton pump inhibitors, and dietary supplements, with the company targeting future expansion into hospital pharmacy tender markets.

Xantis Pharma firmographics

Firmographics
Name
Xantis Pharma
Legal name
Xantis Pharma AG
Website
https://xantispharma.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Xantis Pharma AG is a Swiss-headquartered generic pharmaceutical manufacturer distributing affordable Rx and OTC medicines, anchored by the Sanorin brand, to pharmacies, doctors, and wholesalers across Russia, Ukraine, CIS, and Central Europe.
Ownership category
akta.pro rank

Where Xantis Pharma is headquartered

Location

Headquarters

HQ city
Zug
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

Xantis Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Xantis Pharma generates revenue through the sale of generic prescription (Rx) and over-the-counter (OTC) pharmaceutical products to pharmacies, doctors, and wholesalers. The product portfolio includes branded generics and established OTC brands like Sanorin.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Xantis Pharma product offering

Product offering

Core offering

Xantis Pharma manufactures and distributes a broad portfolio of generic prescription pharmaceuticals, over-the-counter (OTC) medicines, medical devices, and dietary supplements. Its product range covers cardiology, central nervous system, gastroenterology, men's health, allergy, arthritis, pain management, antibiotics, antifungals, and corticosteroids, marketed across Russia, Ukraine, CIS countries, and Central Europe under brands such as Sanorin and Sanimun.

Product overview

Xantis Pharma is a pharmaceutical company focused on making affordable, high-quality generic medicines accessible to those who need them. The company's product portfolio comprises a broad range of offerings organized into distinct categories: (1) The Sanorin OTC sub-brand for cough, cold, and nasal decongestants including Sanorin Aqua medical devices; (2) Prescription medications spanning cardiology (Telmisartan, Perindopril, Furosemid, Rivaroxaban), central-nervous systems (Pregabalin, Zolpidem, Fingolimod), gastroenterology (Itoprid), men's health (Tadalafil, Sildenafil, Silodosin, Dutasterid/Tamsulozin), allergy (Desloratadin), arthritis and pain management (Meloxikam, Paracetamol combinations, Tramadol); (3) Antibiotics (MEGAMOX, CIPROLON, CEDROX, CEFIZOX); (4) Antifungals (Voriconazole); (5) Corticosteroids (Metylprenizolon); and (6) Dietary supplements (Sanimun). The company supplies pharmacies, doctors, and wholesalers in Russia, Ukraine, CIS, and Central Europe, with plans to enter tender markets for hospital pharmacies.

Differentiator

Problem solved

Functional benefit

Brands

  • Sanorin: Leading brand for cough and cold and nasal decongestants. Includes Sanorin 1‰, Sanorin 0.5‰, Sanorin Emulzia, Sanorin Combi, and Sanorin Aqua line of nasal sprays.

Products and services

  • Sanorin OTC brand (cough, cold, nasal decongestants) Over-the-counter Sanorin brand products for cough, cold, and nasal congestion relief, sold to retail pharmacies and consumers in target markets.
  • Sanorin Aqua (medical device nasal sprays)
  • Sanimun (dietary supplement)
  • Carsaxa 100 mg
  • Desloratadin Xantis
  • Entecavir Xantis
  • Furosemid Xantis
  • Itoprid Xantis
  • Perindopril Xantis
  • Telmisartan Xantis (40 mg and 80 mg)
  • Telmisartan/Hydrochlorotiazid Xantis
  • Rivaroxaban Xantis
  • Moxtenz
  • Tadalafil Xantis
  • Sildenafil Xantis
  • Silodosin Xantis
  • Dutasterid/Tamsulozin Xantis
  • Pregabalin Xantis
  • Zolpidem Xantis
  • Fingolimod Xantis
  • Sunitinib Xantis
  • Solixa
  • Azelsan
  • Lanxib
  • Modrasil
  • Paracetamol Xantis
  • Paracetamol/Kofein Xantis
  • Meloxikam Xantis
  • Tramadol/Paracetamol Xantis
  • Tiaprid Xantis
  • Kyselina Acetylsalicylova Xantis (acetylsalicylic acid)
  • Metoprolol Xantis
  • MEGAMOX (amoxicillin)
  • CIPROLON 500 (ciprofloxacin)
  • CEFIZOX (ceftizoxime)
  • CEDROX (cefadroxil)
  • Voriconazole Hikma
  • Metylprenizolon Hikma (methylprednisolone)
  • OPRAZOLE (omeprazole)
  • TRIFED and TRIFED EXPECTORANT

Companies that use Xantis Pharma

Customer profile

Segments4 records

Ideal customer profiles4 records

Xantis Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Xantis Pharma partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Xantis Pharma competitors and assessment

Company assessment

Market position

Weaknesses5 records

Competitive moat3 records

Customer concentration

Xantis Pharma social profiles

Digital presence

Xantis Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Xantis Pharma leadership team

Management profile

Number of profiles

Xantis Pharma subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Xantis Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Xantis Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xantis Pharma

What does Xantis Pharma do?

Xantis Pharma manufactures and distributes a broad portfolio of generic prescription pharmaceuticals, over-the-counter (OTC) medicines, medical devices, and dietary supplements. Its product range covers cardiology, central nervous system, gastroenterology, men's health, allergy, arthritis, pain management, antibiotics, antifungals, and corticosteroids, marketed across Russia, Ukraine, CIS countries, and Central Europe under brands such as Sanorin and Sanimun.

Is Xantis Pharma a public or private company?

Xantis Pharma is a private company. It is classified as unknown and is currently operating.

When was Xantis Pharma founded?

Xantis Pharma was founded in 2015. It employs 501 to 1,000 people.

Where is Xantis Pharma based?

Xantis Pharma is headquartered in Zug, Switzerland, in the Europe region.

How does Xantis Pharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Does Xantis Pharma have an API?

No public API is recorded for Xantis Pharma.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales